QA: Oncorus Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001671818_2022_Oncorus_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001671818, Oncorus Inc

  xvar xval
0 AssetsCurrent 129,110,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 23,233,000
3 remainder_Assets 49,244,000
4 LiabilitiesCurrent 20,974,000
5 LiabilitiesNoncurrent 50,591,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 20,136,000
9 ResearchAndDevelopmentExpense 44,682,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 56,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 201,587,000
1 Liabilities 71,565,000
2 Expenses 64,818,000
3 Revenues 0
4 StockholdersEquity 130,022,000
5 NetIncome -64,762,000
6 ComprehensiveNetIncome -64,762,000
7 BaseVar 169,013,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.60
9 EconomicCapitalRatio 2.75

Edgar->Model Mapping

Feature Distribution